OpenAI researcher in talks to launch $2B AI drug discovery startup

OpenAI researcher Miles Wang is reportedly in discussions to found a new AI-driven drug discovery company with a potential $2 billion valuation. The move highlights the increasing intersection of advanced artificial intelligence and pharmaceutical development. This underscores the growing investor appetite for AI-biotech ventures that could accelerate the creation of new therapies.

Sources (2)